JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.04% |
| 2 | Healthcare | 12.52% |
| 3 | Financials | 10.55% |
| 4 | Consumer Discretionary | 7.88% |
| 5 | Industrials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
Weibo
WB
$1.87B
| $2.13M | ﹤0.01% |
92,058
-156,659
| -63% | -$3.51M |
|
3327
PUT
HUB Group
HUBG
$2.51B
| $2.13M | ﹤0.01% |
+60,000
| New | +$2.1M |
|
3328
FuelCell Energy
FCEL
$1.82B
| $2.12M | ﹤0.01% |
18,859
+1,148
| +6% | +$145K |
|
3329
UNIFI
UFI
$122M
| $2.12M | ﹤0.01% |
150,917
-47,528
| -24% | -$717K |
|
3330
Vir Biotechnology
VIR
$1.54B
| $2.11M | ﹤0.01% |
82,956
+2,983
| +4% | +$69.6K |
|
3331
PUT
Roku
ROKU
$23.4B
| $2.11M | ﹤0.01% |
25,700
+17,200
| +202% | +$1.67M |
|
3332
Protolabs
PRLB
$2.19B
| $2.11M | ﹤0.01% |
44,101
+22,884
| +108% | +$1.06M |
|
3333
PUT
Kohl's
KSS
$2.2B
| $2.11M | ﹤0.01% |
59,100
-128,800
| -69% | -$6.31M |
|
3334
Lexicon Pharmaceuticals
LXRX
$1.03B
| $2.11M | ﹤0.01% |
1,132,777
+3,456
| +0.3% | +$6.59K |
|
3335
Global X Cybersecurity ETF
BUG
$1.52B
| $2.1M | ﹤0.01% |
84,147
+4,934
| +6% | +$136K |
|
3336
Alight
ALIT
$380M
| $2.1M | ﹤0.01% |
15,576
-4,385
| -22% | -$719K |
|
3337
AtriCure
ATRC
$2.23B
| $2.1M | ﹤0.01% |
51,461
+10,494
| +26% | +$497K |
|
3338
Yext
YEXT
$594M
| $2.1M | ﹤0.01% |
439,798
+199,246
| +83% | +$1.11M |
|
3339
CALL
Paycom
PAYC
$9.85B
| $2.1M | ﹤0.01% |
7,500
+6,500
| +650% | +$1.92M |
|
3340
State Street SPDR Portfolio S&P 500 High Dividend ETF
SPYD
$7.79B
| $2.1M | ﹤0.01% |
52,635
-162,252
| -76% | -$6.98M |
|
3341
CALL
NovoCure
NVCR
$1.99B
| $2.1M | ﹤0.01% |
30,200
-23,700
| -44% | -$1.79M |
|
3342
Pricesmart
PSMT
$5.51B
| $2.1M | ﹤0.01% |
29,311
-74,386
| -72% | -$5.77M |
|
3343
Transmedics
TMDX
$3.06B
| $2.1M | ﹤0.01% |
66,727
+53,960
| +423% | +$1.44M |
|
3344
CALL
Exelon
EXC
$47.2B
| $2.1M | ﹤0.01% |
46,300
+9,200
| +25% | +$433K |
|
3345
PubMatic
PUBM
$793M
| $2.1M | ﹤0.01% |
132,016
+45,764
| +53% | +$980K |
|
3346
RCI Hospitality Holdings
RICK
$229M
| $2.09M | ﹤0.01% |
43,287
-943
| -2% | -$54.2K |
|
3347
Occidental Petroleum Corp Warrants
OXY.WS
$34.4B
| – | – |
0
| – | – |
|
|
MRSN
3348
DELISTED
Mersana Therapeutics
MRSN
| $2.08M | ﹤0.01% |
18,046
+5,661
| +46% | +$532K |
|
3349
Schwab International Equity ETF
SCHF
$69.4B
| $2.08M | ﹤0.01% |
132,542
+15,020
| +13% | +$256K |
|
3350
Vanguard Morningstar Mega Cap Growth ETF
MGK
$33.9B
| $2.08M | ﹤0.01% |
57,305
+4,505
| +9% | +$181K |
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,729 reduced and 610 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 610 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.